The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: Selective delivery of boron by boronophenylalanine

Cancer Research

Volumn 61, Issue 24, 2001, Pages 8775-8781

  Kreimann, E L ^a   Itoiz, M E ^a   Dagrosa, A ^a   Garavaglia, R ^a   Farias S ^a   Batistoni, D ^a   Schwint, A E ^a  

^a DEPARTAMENTO DE FÍSICA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

4 BORONOPHENYLALANINE; BORON; DIMETHYLBENZ[A]ANTHRACENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HAMSTER; MOUTH CANCER; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL; RADIOBIOLOGY;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BORON; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CARCINOGENS; CHEEK; CRICETINAE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MESOCRICETUS; MOUTH NEOPLASMS; PHENYLALANINE; RADIATION-SENSITIZING AGENTS; TISSUE DISTRIBUTION;

EID: 0035893390     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Biological effects and therapeutic possibilities of neutrons
2. Detection of nuclear disintegration in a photographic emulsion
3. The relative biological effectiveness in V79 Chinese hamster cells of the neutron capture reaction in boron and nitrogen
4. Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma
5. The radiation biology of boron neutron capture therapy
6. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: Boron concentration correlates with tumor cellularity
7. The effects of boron neutron capture therapy irradiation on oral mucosa: Evaluation using a rat tongue model
8. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy
9. 11SH (BSH) in patients with malignant brain tumors as prerequisite for a phase I clinical trial of boron neutron capture therapy
10. Boron neutron capture therapy: Clinical brain tumor studies
11. Boron neutron capture therapy for glioblastoma multiforme: Interim results for the phase I/II dose-escalation studies
12. A nude rat model for neutron capture therapy of human intracerebral melanoma
13. Boron neutron capture therapy of a murine melanoma with p-boronophenylalanine: Dose-response analysis using a morbidity index
14. Control of intracerebral gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine
15. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex
16. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent
17. Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption
18. Rat brain tumor models in experimental neuro-oncology: The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas
19. Experimental carcinogenesis in the cheek pouch of the Syrian hamster
20. Immunoenhancing agents and experimental leukoplakia and carcinoma of the buccal pouch
21. Creatine kinase iso-enzymes activity in serum and buccal pouch tissue of hamsters during DMBA-induced squamous cell carcinogenesis
22. Lectin binding patterns in squamous epithelium in experimentally induced hamster buccal pouch carcinoma
23. Factors influencing experimental carcinogenesis in the hamster cheek pouch
24. Histochemistry of experimentally induced leukoplakia and carcinoma of the hamster buccal pouch
25. Changes in keratin expression during 7,12-dimethylbenz(a)anthracene-induced hamster cheek pouch carcinogenesis
26. AgNOR mark epithelial foci in malignant transformation in hamster cheek pouch carcinogenesis
27. Anatomical and functional vascular changes in hamster cheek pouch during carcinogenesis induced by 7,12-dimethylbenz(a)anthracene
28. Boron neutron capture therapy: A guide to the understanding of the pathogenesis of late radiation damage to the rat spinal cord
29. Boron neutron capture irradiation of the rat spinal cord: Histopathological evidence of a vascular mediated pathogenesis
30. Time and dose-related changes in the white matter of the brain after single doses of x-rays
31. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma
32. Molecular epidemiology and retinoid chemoprevention of head and neck cancer
33. Chemotherapy of head and neck cancer
34. Recent advance in head and neck surgery
35. In search of new treatment methods for headneck carcinoma
36. Evolution of the radiation therapy oncology group clinical trials for head and neck cancer
37. Multiple primary malignant tumors in patients with head and neck cancer: Results of a prospective study and future perspectives
38. "Field cancerization" in oral stratified squamous epithelium: Clinical implications of multicentric origin
39. Multiple primary cancers of the lung, esophagus and other sites
40. Multiple primary cancers in Hong Kong Chinese patients with squamous cell cancer of the head or neck
41. Tobacco and alcohol consumption in relation to the development of multiple primary cancers
42. Smoking characteristics of patients with oral carcinoma and the risk for second oral primary carcinoma
43. Nucleolar organizer regions in lining epithelium adjacent to squamous cell carcinoma of human oral mucosa
44. 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin
45. Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides
46. Bioavailability of intravenous formulations of p-boronophenylalanine in dog and rat
47. A quantitative histochemical technique for the study of vascularization in tissue sections using horseradish peroxidase
48. Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy
49. Biodistribution of p-borophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy
50. Brain tolerance in dogs to boron neutron capture therapy with borocaptate sodium (BSH) or boronophenylalanine (BPA)
51. BPA and BSH accumulation in experimental tumors
52. Radiobiological evidence suggesting heterogenous microdistribution of boron compounds in tumors: Its relation to quiescent cell population and tumor cure in neutron capture therapy
53. 11SH (BSH) in patients with malignant glioma as a precondition for boron neutron capture therapy (BNCT)
54. 10B concentration for boron neutron capture therapy using prompt gamma-ray analysis
55. A variance in hamster pouch carcinogenesis in tissue irradiated with 200 KVP x-rays and cobalt-60 x-rays
56. Early and late changes in the functional vascularity of the hamster cheek pouch after local x-irradiation
57. Low level X-radiation effects on carcinogenesis by 7,12-dimethylbenz(a)anthracene in syrian hamster cheek pouch epithelium. Acute vs fractionated radiation dose studies